Vyvanse (lisdexamfetamine) continues to gain traction as a vital treatment option for both ADHD and binge eating disorder, distinguished by its unique pharmacological profile that emphasizes safety and efficacy. The medication’s design as a prodrug means that it is metabolized into its active form gradually, which helps prevent the sharp spikes and drops in efficacy often seen with other stimulants.
